Predictors of Improvement Afetr Trasurtheral Resection of Prostate in Patients With Underactive Bladder and Bladder Outlet Obstruction
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Change in international prostate symptome score (IPSS) score.
研究概览
简要总结
The study is for aproved that Transurtheral Resection of prostate is good for patient with underactive bladder or not.
详细描述
Introduction:
Aging men frequently develop lower urinary tract symptoms (LUTS). These symptoms are commonly attributed to bladder outlet obstruction by benign prostatic hyperplasia (BPH) and the clinical condition is termed BPH. However, recent studies have implicated many factors in the pathogenesis of LUTS in addition to BPH. These include prostate inflammation and fibrosis, increased serum estrogen/testosterone ratio, diabetes, the metabolic syndrome, sleep apnea, polyuria and changes in bladder function .
Transurethral resection of prostate (TURP) is a time-tested gold standard surgical option for dealing with LUTS in men having benign prostatic enlargement (BPE) . Persistence of LUTS is reported in 5%-35% of patients undergoing TURP .
Detrusor Under activity (DUA) is defined by the International Continence Society (ICS) as "a contraction of reduced strength and/or duration, resulting in prolonged bladder emptying and/or failure to achieve complete bladder emptying within a normal time span" . Detrusor underactivity was demonstrated in 17% men presenting with LUTS after urodynamic evaluation .
Male DUA definition remains controversial and no effective treatment is consolidated. The role of prostatic surgery in male DUA is not clear. The primary endpoint was the clinical and voiding improvement based on International Prostate Symptom Score (IPSS) and the maximum flow rate in uroflowmetry (Qmax) within 12 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 70 Years(Adult, Older Adult)
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Male patients diagnosed with BOO and UAB
- •Age ≥ 40 years.
排除标准
- •Patient insulin dependent diabetes
- •Patient with history of cerbrovascular stroke or hemarrage.
- •History of prior prostate surgery.
- •Urethral pathology or surgery.
- •Patient with prostate or bladder cancer.
- •Spinal and pelvic trauma or surgery.
结局指标
主要结局
Change in international prostate symptome score (IPSS) score.
时间窗: 3 month .
Outcome measure Detrusar pressure at maximum flow (Pdet-Qmax unit:CmH2O)
次要结局
未报告次要终点
研究者
Emad Abdellah Ali Mostafa
Director,Head of urology,Principal investigator,clinical professor
Sohag University
